EOFLOW Co.,Ltd.

KOSDAQ 294090.KQ

EOFLOW Co.,Ltd. EBITDA Margin for the year ending December 31, 2023: -616.87%

EOFLOW Co.,Ltd. EBITDA Margin is -616.87% for the year ending December 31, 2023, a -60.05% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

EOFLOW Co.,Ltd. EBITDA Margin for the year ending December 31, 2022 was -385.42%, a 88.98% change year over year.
EOFLOW Co.,Ltd. EBITDA Margin for the year ending December 31, 2021 was -3,496.05%, a 95.92% change year over year.
EOFLOW Co.,Ltd. EBITDA Margin for the year ending December 31, 2020 was -85,710.83%.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

KOSDAQ: 294090.KQ

EOFLOW Co.,Ltd.

CEO	Mr. Jaejin Kim
IPO Date	Sept. 14, 2020
Location	South Korea
Headquarters	Healthcare Innovation Park Number H2102
Employees	121
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

EOFLOW Co.,Ltd. develops and provides drug delivery solutions. The company offers EOPatch, a wearable insulin pump system. EOFLOW Co.,Ltd. is based in Seongnam, South Korea.

Key trends

Past 5 years